HEADER TRANSFERASE 08-FEB-06 2FYO TITLE CRYSTAL STRUCTURE OF RAT CARNITINE PALMITOYLTRANSFERASE 2 IN SPACE TITLE 2 GROUP P43212 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARNITINE O-PALMITOYLTRANSFERASE II, MITOCHONDRIAL; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CPT II; COMPND 5 EC: 2.3.1.21; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: B834(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS CENTRAL SIX-STRANDED BETA-SHEET, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.C.RUFER,R.THOMA,J.BENZ,M.STIHLE,B.GSELL,E.DE ROO,D.W.BANNER, AUTHOR 2 F.MUELLER,O.CHOMIENNE,M.HENNIG REVDAT 3 18-OCT-17 2FYO 1 REMARK REVDAT 2 24-FEB-09 2FYO 1 VERSN REVDAT 1 08-FEB-07 2FYO 0 JRNL AUTH A.C.RUFER,R.THOMA,J.BENZ,M.STIHLE,B.GSELL,E.DE ROO, JRNL AUTH 2 D.W.BANNER,F.MUELLER,O.CHOMIENNE,M.HENNIG JRNL TITL THE CRYSTAL STRUCTURE OF CARNITINE PALMITOYLTRANSFERASE 2 JRNL TITL 2 AND IMPLICATIONS FOR DIABETES TREATMENT JRNL REF STRUCTURE V. 14 713 2006 JRNL REFN ISSN 0969-2126 JRNL PMID 16615901 JRNL DOI 10.1016/J.STR.2006.01.008 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 46957 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2507 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3347 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.1850 REMARK 3 BIN FREE R VALUE SET COUNT : 200 REMARK 3 BIN FREE R VALUE : 0.2570 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4976 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 525 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.18000 REMARK 3 B22 (A**2) : -0.18000 REMARK 3 B33 (A**2) : 0.37000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.171 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.163 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.109 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.779 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.907 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5103 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6923 ; 1.161 ; 1.950 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 624 ; 5.736 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 247 ;34.944 ;23.887 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 846 ;12.740 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;17.514 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 756 ; 0.078 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3932 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2567 ; 0.202 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3536 ; 0.300 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 530 ; 0.152 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 43 ; 0.191 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 27 ; 0.134 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3214 ; 1.340 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5045 ; 1.901 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2131 ; 3.191 ; 4.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1878 ; 4.468 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. THE STRUCTURE WAS MEASURED IN MAD MODE BUT ONLY A REMARK 3 SINGLE (PEAK) WAVELENGTH WAS USED FOR SOLVING THE STRUCTRE WITH REMARK 3 MOLECULAR REPLACEMENT. DUE TO A MISTAKE IN BEAM-LINE CALIBRATION REMARK 3 THE ACTUAL INFLECTION AND PEAK WAVELLENGTHS WERE MISSED. REMARK 4 REMARK 4 2FYO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-FEB-06. REMARK 100 THE DEPOSITION ID IS D_1000036468. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JUN-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97853 REMARK 200 MONOCHROMATOR : LN2 COOLED FIXED-EXIT SI(111) REMARK 200 MONOCHROMATOR (19.65M, FOCUSING REMARK 200 SAGITTAL-HORIZONTAL) BENDABLE REMARK 200 MIRROR (20.50M FOCUSING REMARK 200 MERIDIONAL-VERTICAL) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49466 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 23.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.03100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 28.0400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.07400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 14.80 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.15 M DL-MALIC ACID 20 % (W/V) REMARK 280 PEG3350, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 153.64000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 33.77500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 33.77500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 230.46000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 33.77500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 33.77500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 76.82000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 33.77500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 33.77500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 230.46000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 33.77500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 33.77500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 76.82000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 153.64000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 6 REMARK 465 GLY A 7 REMARK 465 SER A 8 REMARK 465 SER A 9 REMARK 465 HIS A 10 REMARK 465 HIS A 11 REMARK 465 HIS A 12 REMARK 465 HIS A 13 REMARK 465 HIS A 14 REMARK 465 HIS A 15 REMARK 465 SER A 16 REMARK 465 SER A 17 REMARK 465 GLY A 18 REMARK 465 LEU A 19 REMARK 465 VAL A 20 REMARK 465 PRO A 21 REMARK 465 ARG A 22 REMARK 465 GLY A 23 REMARK 465 SER A 24 REMARK 465 HIS A 25 REMARK 465 MET A 26 REMARK 465 ALA A 27 REMARK 465 VAL A 28 REMARK 465 SER A 29 REMARK 465 GLY A 30 REMARK 465 PRO A 31 REMARK 465 LYS A 657 REMARK 465 THR A 658 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1175 O HOH A 1176 2.01 REMARK 500 O HOH A 966 O HOH A 1169 2.16 REMARK 500 CZ ARG A 350 O HOH A 1135 2.18 REMARK 500 NE ARG A 350 O HOH A 1135 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 129 -52.41 71.00 REMARK 500 PHE A 131 -44.68 -130.77 REMARK 500 ASP A 184 57.00 -91.96 REMARK 500 ASN A 230 -46.58 69.36 REMARK 500 PRO A 284 154.30 -49.63 REMARK 500 ASP A 329 52.53 -103.25 REMARK 500 HIS A 344 -31.34 -140.99 REMARK 500 ALA A 405 89.32 -68.73 REMARK 500 ARG A 498 -115.39 -127.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2FW3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RAT CARNITINE PALMITOYLTRANSFERASE 2 IN REMARK 900 COMPLEX WITH ANTIDIABETIC DRUG ST1326 REMARK 900 RELATED ID: 2DEB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RAT CARNITINE PALMITOYLTRANSFERASE 2 IN SPACE REMARK 900 GROUP C2221 DBREF 2FYO A 27 658 UNP P18886 CPT2_RAT 27 658 SEQADV 2FYO MET A 6 UNP P18886 EXPRESSION TAG SEQADV 2FYO GLY A 7 UNP P18886 EXPRESSION TAG SEQADV 2FYO SER A 8 UNP P18886 EXPRESSION TAG SEQADV 2FYO SER A 9 UNP P18886 EXPRESSION TAG SEQADV 2FYO HIS A 10 UNP P18886 EXPRESSION TAG SEQADV 2FYO HIS A 11 UNP P18886 EXPRESSION TAG SEQADV 2FYO HIS A 12 UNP P18886 EXPRESSION TAG SEQADV 2FYO HIS A 13 UNP P18886 EXPRESSION TAG SEQADV 2FYO HIS A 14 UNP P18886 EXPRESSION TAG SEQADV 2FYO HIS A 15 UNP P18886 EXPRESSION TAG SEQADV 2FYO SER A 16 UNP P18886 EXPRESSION TAG SEQADV 2FYO SER A 17 UNP P18886 EXPRESSION TAG SEQADV 2FYO GLY A 18 UNP P18886 EXPRESSION TAG SEQADV 2FYO LEU A 19 UNP P18886 EXPRESSION TAG SEQADV 2FYO VAL A 20 UNP P18886 EXPRESSION TAG SEQADV 2FYO PRO A 21 UNP P18886 EXPRESSION TAG SEQADV 2FYO ARG A 22 UNP P18886 EXPRESSION TAG SEQADV 2FYO GLY A 23 UNP P18886 EXPRESSION TAG SEQADV 2FYO SER A 24 UNP P18886 EXPRESSION TAG SEQADV 2FYO HIS A 25 UNP P18886 EXPRESSION TAG SEQADV 2FYO MET A 26 UNP P18886 EXPRESSION TAG SEQADV 2FYO MSE A 43 UNP P18886 MET 43 MODIFIED RESIDUE SEQADV 2FYO MSE A 61 UNP P18886 MET 61 MODIFIED RESIDUE SEQADV 2FYO MSE A 119 UNP P18886 MET 119 MODIFIED RESIDUE SEQADV 2FYO MSE A 135 UNP P18886 MET 135 MODIFIED RESIDUE SEQADV 2FYO MSE A 214 UNP P18886 MET 214 MODIFIED RESIDUE SEQADV 2FYO MSE A 332 UNP P18886 MET 332 MODIFIED RESIDUE SEQADV 2FYO MSE A 342 UNP P18886 MET 342 MODIFIED RESIDUE SEQADV 2FYO MSE A 473 UNP P18886 MET 473 MODIFIED RESIDUE SEQADV 2FYO MSE A 531 UNP P18886 MET 531 MODIFIED RESIDUE SEQADV 2FYO MSE A 532 UNP P18886 MET 532 MODIFIED RESIDUE SEQADV 2FYO MSE A 548 UNP P18886 MET 548 MODIFIED RESIDUE SEQADV 2FYO MSE A 582 UNP P18886 MET 582 MODIFIED RESIDUE SEQRES 1 A 653 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 653 LEU VAL PRO ARG GLY SER HIS MET ALA VAL SER GLY PRO SEQRES 3 A 653 ASP ASP TYR LEU GLN HIS SER ILE VAL PRO THR MSE HIS SEQRES 4 A 653 TYR GLN ASP SER LEU PRO ARG LEU PRO ILE PRO LYS LEU SEQRES 5 A 653 GLU ASP THR MSE LYS ARG TYR LEU ASN ALA GLN LYS PRO SEQRES 6 A 653 LEU LEU ASP ASP SER GLN PHE ARG ARG THR GLU ALA LEU SEQRES 7 A 653 CYS LYS ASN PHE GLU THR GLY VAL GLY LYS GLU LEU HIS SEQRES 8 A 653 ALA HIS LEU LEU ALA GLN ASP LYS GLN ASN LYS HIS THR SEQRES 9 A 653 SER TYR ILE SER GLY PRO TRP PHE ASP MSE TYR LEU THR SEQRES 10 A 653 ALA ARG ASP SER ILE VAL LEU ASN PHE ASN PRO PHE MSE SEQRES 11 A 653 ALA PHE ASN PRO ASP PRO LYS SER GLU TYR ASN ASP GLN SEQRES 12 A 653 LEU THR ARG ALA THR ASN LEU THR VAL SER ALA VAL ARG SEQRES 13 A 653 PHE LEU LYS THR LEU GLN ALA GLY LEU LEU GLU PRO GLU SEQRES 14 A 653 VAL PHE HIS LEU ASN PRO SER LYS SER ASP THR ASP ALA SEQRES 15 A 653 PHE LYS ARG LEU ILE ARG PHE VAL PRO PRO SER LEU SER SEQRES 16 A 653 TRP TYR GLY ALA TYR LEU VAL ASN ALA TYR PRO LEU ASP SEQRES 17 A 653 MSE SER GLN TYR PHE ARG LEU PHE ASN SER THR ARG ILE SEQRES 18 A 653 PRO ARG PRO ASN ARG ASP GLU LEU PHE THR ASP THR LYS SEQRES 19 A 653 ALA ARG HIS LEU LEU VAL LEU ARG LYS GLY HIS PHE TYR SEQRES 20 A 653 VAL PHE ASP VAL LEU ASP GLN ASP GLY ASN ILE VAL ASN SEQRES 21 A 653 PRO LEU GLU ILE GLN ALA HIS LEU LYS TYR ILE LEU SER SEQRES 22 A 653 ASP SER SER PRO VAL PRO GLU PHE PRO VAL ALA TYR LEU SEQRES 23 A 653 THR SER GLU ASN ARG ASP VAL TRP ALA GLU LEU ARG GLN SEQRES 24 A 653 LYS LEU ILE PHE ASP GLY ASN GLU GLU THR LEU LYS LYS SEQRES 25 A 653 VAL ASP SER ALA VAL PHE CYS LEU CYS LEU ASP ASP PHE SEQRES 26 A 653 PRO MSE LYS ASP LEU ILE HIS LEU SER HIS THR MSE LEU SEQRES 27 A 653 HIS GLY ASP GLY THR ASN ARG TRP PHE ASP LYS SER PHE SEQRES 28 A 653 ASN LEU ILE VAL ALA GLU ASP GLY THR ALA ALA VAL HIS SEQRES 29 A 653 PHE GLU HIS SER TRP GLY ASP GLY VAL ALA VAL LEU ARG SEQRES 30 A 653 PHE PHE ASN GLU VAL PHE ARG ASP SER THR GLN THR PRO SEQRES 31 A 653 ALA ILE THR PRO GLN SER GLN PRO ALA ALA THR ASN SER SEQRES 32 A 653 SER ALA SER VAL GLU THR LEU SER PHE ASN LEU SER GLY SEQRES 33 A 653 ALA LEU LYS ALA GLY ILE THR ALA ALA LYS GLU LYS PHE SEQRES 34 A 653 ASP THR THR VAL LYS THR LEU SER ILE ASP SER ILE GLN SEQRES 35 A 653 PHE GLN ARG GLY GLY LYS GLU PHE LEU LYS LYS LYS GLN SEQRES 36 A 653 LEU SER PRO ASP ALA VAL ALA GLN LEU ALA PHE GLN MSE SEQRES 37 A 653 ALA PHE LEU ARG GLN TYR GLY GLN THR VAL ALA THR TYR SEQRES 38 A 653 GLU SER CYS SER THR ALA ALA PHE LYS HIS GLY ARG THR SEQRES 39 A 653 GLU THR ILE ARG PRO ALA SER ILE PHE THR LYS ARG CYS SEQRES 40 A 653 SER GLU ALA PHE VAL ARG ASP PRO SER LYS HIS SER VAL SEQRES 41 A 653 GLY GLU LEU GLN HIS MSE MSE ALA GLU CYS SER LYS TYR SEQRES 42 A 653 HIS GLY GLN LEU THR LYS GLU ALA ALA MSE GLY GLN GLY SEQRES 43 A 653 PHE ASP ARG HIS LEU TYR ALA LEU ARG TYR LEU ALA THR SEQRES 44 A 653 ALA ARG GLY LEU ASN LEU PRO GLU LEU TYR LEU ASP PRO SEQRES 45 A 653 ALA TYR GLN GLN MSE ASN HIS ASN ILE LEU SER THR SER SEQRES 46 A 653 THR LEU ASN SER PRO ALA VAL SER LEU GLY GLY PHE ALA SEQRES 47 A 653 PRO VAL VAL PRO ASP GLY PHE GLY ILE ALA TYR ALA VAL SEQRES 48 A 653 HIS ASP ASP TRP ILE GLY CYS ASN VAL SER SER TYR SER SEQRES 49 A 653 GLY ARG ASN ALA ARG GLU PHE LEU HIS CYS VAL GLN LYS SEQRES 50 A 653 CYS LEU GLU ASP ILE PHE ASP ALA LEU GLU GLY LYS ALA SEQRES 51 A 653 ILE LYS THR MODRES 2FYO MSE A 43 MET SELENOMETHIONINE MODRES 2FYO MSE A 61 MET SELENOMETHIONINE MODRES 2FYO MSE A 119 MET SELENOMETHIONINE MODRES 2FYO MSE A 135 MET SELENOMETHIONINE MODRES 2FYO MSE A 214 MET SELENOMETHIONINE MODRES 2FYO MSE A 332 MET SELENOMETHIONINE MODRES 2FYO MSE A 342 MET SELENOMETHIONINE MODRES 2FYO MSE A 473 MET SELENOMETHIONINE MODRES 2FYO MSE A 531 MET SELENOMETHIONINE MODRES 2FYO MSE A 532 MET SELENOMETHIONINE MODRES 2FYO MSE A 548 MET SELENOMETHIONINE MODRES 2FYO MSE A 582 MET SELENOMETHIONINE HET MSE A 43 8 HET MSE A 61 8 HET MSE A 119 8 HET MSE A 135 8 HET MSE A 214 8 HET MSE A 332 8 HET MSE A 342 8 HET MSE A 473 8 HET MSE A 531 8 HET MSE A 532 8 HET MSE A 548 8 HET MSE A 582 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 12(C5 H11 N O2 SE) FORMUL 2 HOH *525(H2 O) HELIX 1 1 TYR A 45 LEU A 49 5 5 HELIX 2 2 LYS A 56 LYS A 69 1 14 HELIX 3 3 ASP A 73 GLY A 90 1 18 HELIX 4 4 GLY A 90 ASN A 106 1 17 HELIX 5 5 ILE A 112 ALA A 123 1 12 HELIX 6 6 LYS A 142 ASN A 146 5 5 HELIX 7 7 ASP A 147 ALA A 168 1 22 HELIX 8 8 ASN A 179 ASP A 184 1 6 HELIX 9 9 THR A 185 ARG A 193 1 9 HELIX 10 10 LEU A 199 LEU A 206 1 8 HELIX 11 11 GLN A 216 PHE A 221 5 6 HELIX 12 12 ASN A 265 SER A 278 1 14 HELIX 13 13 PRO A 287 GLU A 294 5 8 HELIX 14 14 ASN A 295 ASP A 309 1 15 HELIX 15 15 ASN A 311 SER A 320 1 10 HELIX 16 16 ASP A 334 HIS A 344 1 11 HELIX 17 17 GLY A 377 THR A 394 1 18 HELIX 18 18 ASN A 407 VAL A 412 1 6 HELIX 19 19 SER A 420 THR A 440 1 21 HELIX 20 20 GLY A 452 LYS A 459 1 8 HELIX 21 21 SER A 462 GLY A 480 1 19 HELIX 22 22 SER A 506 ARG A 518 1 13 HELIX 23 23 ASP A 519 HIS A 523 5 5 HELIX 24 24 SER A 524 MSE A 548 1 25 HELIX 25 25 PHE A 552 ARG A 566 1 15 HELIX 26 26 PRO A 571 LEU A 575 5 5 HELIX 27 27 ASP A 576 ASN A 583 1 8 HELIX 28 28 ASN A 632 GLY A 653 1 22 SHEET 1 A 8 GLU A 413 THR A 414 0 SHEET 2 A 8 HIS A 250 ASP A 255 -1 N VAL A 253 O GLU A 413 SHEET 3 A 8 HIS A 242 ARG A 247 -1 N LEU A 243 O PHE A 254 SHEET 4 A 8 CYS A 324 LEU A 327 1 O LEU A 325 N LEU A 244 SHEET 5 A 8 PHE A 356 VAL A 360 1 O LEU A 358 N CYS A 326 SHEET 6 A 8 ALA A 366 PHE A 370 -1 O HIS A 369 N ASN A 357 SHEET 7 A 8 PHE A 134 PHE A 137 -1 N PHE A 137 O ALA A 366 SHEET 8 A 8 VAL A 597 GLY A 601 -1 O LEU A 599 N ALA A 136 SHEET 1 B 2 VAL A 175 HIS A 177 0 SHEET 2 B 2 ALA A 209 PRO A 211 -1 O TYR A 210 N PHE A 176 SHEET 1 C 2 SER A 223 ILE A 226 0 SHEET 2 C 2 GLU A 233 THR A 236 -1 O GLU A 233 N ILE A 226 SHEET 1 D 6 SER A 442 PHE A 448 0 SHEET 2 D 6 ILE A 621 SER A 627 -1 O VAL A 625 N ASP A 444 SHEET 3 D 6 PHE A 610 VAL A 616 -1 N ALA A 613 O ASN A 624 SHEET 4 D 6 LEU A 587 THR A 591 1 N SER A 588 O ILE A 612 SHEET 5 D 6 THR A 485 SER A 490 1 N TYR A 486 O LEU A 587 SHEET 6 D 6 THR A 499 ILE A 502 -1 O ILE A 502 N GLU A 487 LINK C THR A 42 N MSE A 43 1555 1555 1.33 LINK C MSE A 43 N HIS A 44 1555 1555 1.33 LINK C THR A 60 N MSE A 61 1555 1555 1.33 LINK C MSE A 61 N LYS A 62 1555 1555 1.33 LINK C ASP A 118 N MSE A 119 1555 1555 1.33 LINK C MSE A 119 N TYR A 120 1555 1555 1.33 LINK C PHE A 134 N MSE A 135 1555 1555 1.33 LINK C MSE A 135 N ALA A 136 1555 1555 1.33 LINK C ASP A 213 N MSE A 214 1555 1555 1.33 LINK C MSE A 214 N SER A 215 1555 1555 1.32 LINK C PRO A 331 N MSE A 332 1555 1555 1.33 LINK C MSE A 332 N LYS A 333 1555 1555 1.33 LINK C THR A 341 N MSE A 342 1555 1555 1.33 LINK C MSE A 342 N LEU A 343 1555 1555 1.33 LINK C GLN A 472 N MSE A 473 1555 1555 1.33 LINK C MSE A 473 N ALA A 474 1555 1555 1.33 LINK C HIS A 530 N MSE A 531 1555 1555 1.33 LINK C MSE A 531 N MSE A 532 1555 1555 1.33 LINK C MSE A 532 N ALA A 533 1555 1555 1.33 LINK C ALA A 547 N MSE A 548 1555 1555 1.34 LINK C MSE A 548 N GLY A 549 1555 1555 1.34 LINK C GLN A 581 N MSE A 582 1555 1555 1.34 LINK C MSE A 582 N ASN A 583 1555 1555 1.33 CRYST1 67.550 67.550 307.280 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014804 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014804 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003254 0.00000